Adagrasib Shows Promising Activity in Gastrointestinal Cancers By Alan P. Lyss, MD Publish Date February 4, 2022 In the KRYSTAL-1 trial, adagrasib produced a 100% disease control rate in patients with gastrointestinal cancers.
Phase 3 Studies Herald More Options for Metastatic Breast Cancer By Alan P. Lyss, MD Publish Date January 14, 2022 Dr Alan Lyss details the results and clinical implications of the EMERALD, PHOEBE, and DESTINY-Breast03 trials.
We Can Treat Hodgkin’s Lymphoma Like Melanoma? By Isabel Cunningham, MD Publish Date September 3, 2015 Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.
Books, Movies, and Journaling Aid Coping During, After Cancer Treatment By Sarah Tennenhaus, LMSW CancerCare Publish Date May 12, 2022 An exploration of complementary therapies that help patients cope during and after treatment for cancer.
Eponyms in Oncology: Zollinger-Ellison Syndrome By Alan P. Lyss, MD Publish Date May 10, 2022 This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Zollinger-Ellison syndrome.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years By Victoria Forster, PhD Publish Date May 6, 2022 Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.